Injured by Zyprexa Side Effects?
Breaking News: The drug maker Eli Lilly has engaged in a decade-long effort to play down the health risks (Diabetes, Hyperglycemia, Ketoacidosis, Pancreatitis, and in some cases diabetic coma or death) of Zyprexa, its best-selling medication for schizophrenia, according to hundreds of internal Lilly documents and e-mail messages among top company managers >>> Read More
The popular atypical antipsychotic drug Zyprexa (Generic: olanzapine) used by millions of Americans to Schizophrenia and bipolar disorder has been linked to, high blood sugar and Diabetes, Hyperglycemia, Ketoacidosis, Pancreatitis, Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia (TD), Diabetic Comas and death.
Update: Schmidt & Clark is no longer accepting Zyprexa cases.
What is the problem?
Zyprexa is a drug marketed by Eli Lilly and is in a class of drugs called atypical antipsychotics, which are used to treat schizophrenia, bipolar disorder, anxiety and sleep disorders.
Eli Lilly, has been instructed by the Food and Drug Administration (FDA) to place new warnings on labels and packaging to the commonly used schizophrenia drug Zyprexa.
Zyprexa has been linked to diabetes and multiple blood sugar level disorders. Recent study shows atypical antipsychotic drugs like Zyprexa used in treatment of schizophrenia, appear to cause diabetes at a rate nearly 50 percent higher than previous generation drugs.
Zyprexa Side Effects
The FDA has issued a public health advisory regarding the following serious and life-threatening adverse side effects of Zyprexa:
- Diabetes
- Hyperglycemia
- Ketoacidosis
- Pancreatitis
- Diabetic coma
- Death
Zyprexa Side Effects & Lawsuit News (National)
| AstraZeneca: new Seroquel label cannot prevent the inevitable - Pharmaceutical Business Review Considered to be the most widely applicable antipsychotic, Seroquel, launched in 1997 for the treatment of schizophrenia, continues to gain market share at a strong annual rate. In the seven major markets Seroquel sales, including those for Seroquel ... The Shrink's Progress - American Reporter ORINDA, Calif. -- Debbie, a 17-year-old now down to 86 pounds and ever closer to her secret goal of 81 pounds, slowly awoke in her bed on a hospital intensive care unit. She was so groggy from her drug overdose that the only thing she noticed was the ... Shrink's Progress - American Reporter ORINDA, Calif. -- Roger screamed repeatedly as he marched down the middle of Main Street: "I'll kill all of you terrorist b--tards!" He waved a large crowbar like a baseball bat. His huge tattooed arms and thick neck protruding from a black T-shirt ... Lilly updates warning label information on 2 drugs - WTHR Indianapolis - Eli Lilly and Co. has updated warning information on the labels it attaches to two of its drugs. The drug maker added new warnings about weight gain and high cholesterol and updated its high blood sugar warning for Zyprexa and Symbyax ... State claims Lilly tried to blur Zyprexa-diabetes link - Anchorage Daily News Back in 2002, Eli Lilly and Co. came up with a $10 million effort to ramp up sales of its schizophrenia medicine, Zyprexa. They called it Project "BAD." Among other things, the company wanted to reduce the "negative aspect" of links between Zyprexa ... API patients on Zyprexa got diabetes, official says - Anchorage Daily News Patients taking the anti-psychotic drug Zyprexa needlessly developed diabetes because doctors didn't have all the information about risks, the medical director of Alaska's only public mental hospital said in court Wednesday. The state of Alaska is ... 'Serious Safety Concern' for Zyprexa - ABC News You've requested an ABCNews.com page that does not exist. If you've reached this page by selecting a bookmark that worked previously, it's likely the file moved to a new location because of our recent redesign. Please update your bookmarks. If you ... Study Questions 'Off-Label' Use of Antipsychotics - HealthCentral.com Copyright © 2007 ScoutNews, LLC. All rights reserved. FRIDAY, Jan. 19 (HealthDay News) -- Newer antipsychotic medications are being used widely for a variety of psychiatric disorders for which they were not initially approved. This "off label" use ... The Daily Weekly News, Politics, and Media - Seattle Weekly Stay up-to-date with the Seattle Weekly. We'll e-mail you a detailed rundown of what's on seattleweekly.com once a week. Signing up is simple and you can opt out anytime. Give it a try . In the 1990s, there was a small, quiet revolution in American ... Sector Wrap: Cost cuts, weak dollar drive pharma earnings - CNBC NEW YORK - The week saw a flurry of quarterly earnings reports from the pharmaceutical sector, many marred by lower revenue in the face of rising generic competition. Whereas blockbuster drug sales are typically the key driver of big pharma's profit ... |
